Chronic pain management issues in the primary care setting and the utility of long-acting opioids

Expert Opinion on Pharmacotherapy

Volumn 11, Issue 11, 2010, Pages 1823-1833

  Zorba Paster, Robert ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b DEAN MEDICAL CENTER   (United States)

Author keywords

Chronic pain; Controlled release opioids; Extended release opioids; Long acting opioids; Sustained release opioids; Transdermal opioids; Treatment

Indexed keywords

HYDROCODONE; MORPHINE SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPANA; OPIATE DERIVATIVE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; OXYMORPHONE; PARACETAMOL; TRAMADOL; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT;

AMENORRHEA; ANEMIA; ARTHRITIS; CHRONIC PAIN; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DIZZINESS; DRUG DEPENDENCE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; EVENING DOSAGE; FATIGUE; HEADACHE; HEALTH CARE COST; HIP OSTEOARTHRITIS; HOT FLUSH; HUMAN; HYPOGONADISM; INSOMNIA; KNEE OSTEOARTHRITIS; LIBIDO DISORDER; LOW BACK PAIN; MORNING DOSAGE; MUSCLE ATROPHY; NAUSEA; OPIATE ADDICTION; OSTEOARTHRITIS; OSTEOPOROSIS; PAIN ASSESSMENT; PRIMARY MEDICAL CARE; PRURITUS; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; TREATMENT OUTCOME; UNITED STATES; VOMITING; XEROSTOMIA; CHRONIC DISEASE; PAIN; PRIMARY HEALTH CARE;

ANALGESICS, OPIOID; CHRONIC DISEASE; HUMANS; PAIN; PRIMARY HEALTH CARE;

EID: 77954798206     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2010.491510     Document Type: Review

References (74)

1. Brunton S. Approach to assessment and diagnosis of chronic pain. J Fam Pract 2004;53(Suppl):S3-10
2. Smith BH, Hopton JL, Chambers WA. Chronic pain in primary care. Fam Pract 1999;16:475-482
3. Peter D Hart Research Associates. Americans talk about pain. A survey among adults nationwide conducted for Research America. Available from: www.researchamerica.org/polldata/2003/ painpoll03.pdf. [Last accessed 28 November 2007]
4. Ashburn MA, Staats PS. Management of chronic pain. Lancet 1999;353:1865-1869
5. Allen H, Hubbard D, Sullivan S. The burden of pain on employee health and productivity at a major provider of business services. J Occup Environ Med 2005;47:658-670
6. Otis JD, Keane TM, Kerns RD. An examination of the relationship between chronic pain and post-traumatic stress disorder. J Rehabil Res Dev 2003;40:397-405
7. Romano JM, Turner JA. Chronic pain and depression: does the evidence support a relationship? Psychol Bull 1985;97:18-34
8. Deardorff W. Breaking the cycle of chronic pain and insomnia. Available from: topics/conserv/insomnia/insomnia1.html. [Last accessed 21 February 2007]
9. Cohen MJM, Menefee LA, Doghramji K, et al. Sleep in chronic pain: problems and treatments. Int Rev Psychiatry 2000;12:115-126
10. Katz WA. Musculoskeletal pain and its socioeconomic implications. Clin Rheumatol 2002;21:S2-4
11. Ortho-McNeil Pharmaceutical. 1999 National Pain Survey. Available from: LINKS/FULL/1999-National-Pain- Survey.html. [Last accessed 21 February 2007]
12. Vorsanger GJ, Gallagher R. Negative impact of chronic pain on workers and employers. Poster presented at the 18th Annual Clinical Meeting of the American Academy of Pain Management, e27 - 30 September 2007; Las Vegas, NV, USA
13. Department of Health and Human Services, National Institutes of Health. New Directions in Pain Research: I. Available from: grants/guide/pa-files/PA-98- 102.html. [Last accessed 21 February 2007]
14. Americans Living with Pain Survey. Executive Summary of Results. Survey conducted on behalf of the American Chronic Pain Association. Sponsored by Endo Pharmaceuticals. April 2004. Available from: documents/FINAL%20PAIN% 20SURVEY%20RESULTS% 20REPORT.pdf. [Last accessed 21 February 2007]
15. Podichetty VK, Mazanec DJ, Biscup RS. Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention. Postgrad Med J 2003;79:627-633
16. Chronic Pain in America: Roadblocks to Relief. A study conducted by Roper Starch Worldwide for American Academy of Pain Medicine, American Pain Society and Janssen Pharmaceutica; 1999. Available from: www.ampainsoc.org/links/ roadblocks/ . [Last accessed 21 February 2007]
17. McCarberg B, Lande SD. APS Managed Care Forum on Pain. Available from: bulletin/may00/forum1.htm. [Last accessed 28 July 2008]
18. Joshi GP, Ogunnaike BO. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesthesiol Clin North America 2005;23:21-36
19. Brookoff D. Chronic pain: 1. A new disease? Hosp Pract (Minneap) 2000;35:45-52,59
20. Drewes AM. Pain and sleep disturbances with special reference to fibromyalgia and rheumatoid arthritis. Rheumatology (Oxf) 1999;38:1035-1038
21. Drewes AM, Arendt-Nielsen L. Pain and sleep in medical diseases: interactions and treatment possibilities. A review. Sleep Res Online 2001;4:67-76
22. Kundermann B, Spernal J, Huber MT, et al. Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers. Psychosom Med 2004;66:932-937
23. Atkinson JH, Slater MA, Patterson TL, et al. Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: a controlled study. Pain 1991;45:111-121
24. Davis MP, Srivastava M. Demographics, assessment and management of pain in the elderly. Drugs Aging 2003;20:23-57
25. Gloth MJ, Matesi AM. Physical therapy and exercise in pain management. Clin Geriatr Med 2001;17:525-535,vii
26. American College of Rheumatology. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-1915
27. Wong M, Rietzschel J, Mulherin D, David C. Evaluation of a multidisciplinary outpatient pain management programme based at a community hospital. Musculoskeletal Care 2009;7:106-120
28. Stanos S, Houle TT. Multidisciplinary and interdisciplinary management of chronic pain. Phys Med Rehabil Clin N Am 2006;17:435-450,vii
29. Stanos SP, McLean J, Rader L. Physical medicine rehabilitation approach to pain. Med Clin North Am 2007;91:57-95 (Pubitemid 44880057)
30. Adams EH, Breiner S, Cicero TJ, et al. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage 2006;31:465-476
31. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006;6:46
32. Gilson AM, Kreis PG. The burden of the nonmedical use of prescription opioid analgesics. Pain Med 2009;10(Suppl 2):S89-100
33. Daniell HW. Opioid-induced androgen deficiency. Curr Opin Endocrinol Diabetes 2006;13:262-266
34. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002;3:377-384
35. Fraser LA, Morrison D, Morley-Forster P, et al. Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes 2009;117:38-43
36. Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215-2222
37. Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage 1994;9:126-131
38. Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, et al. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 2004;100:851-858
39. Roberts LJ, Finch PM, Pullan PT, et al. Sex hormone suppression by intrathecal opioids: a prospective study. Clin J Pain 2002;18:144-148
40. Wisconsin Medical Society Task Force on Pain Management. Guidelines for the assessment and management of chronic pain. WMJ 2004;103:13-42
41. Trescot AM, Boswell MV, Atluri SL, et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006;9:1-39
42. Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:131-146
43. Myths and facts about long-acting opioids in chronic pain: a multidisciplinary analysis. ONS News 2004;19:55-56
44. Collett BJ. Chronic opioid therapy for non-cancer pain. Br J Anaesth 2001;87:133-143
45. Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63:17-32
46. Vallerand AH. The use of long-acting opioids in chronic pain management. Nurs Clin North Am 2003;38:435-445
47. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-1310
48. Manchikanti L, Atluri S, Trescot AM, Giordano J. Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility. Pain Physician 2008;11:S155-80
49. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 2008;24:497-508
50. Moore TM, Jones T, Browder JH, et al. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med 2009;10:1426-1433
51. Butler SF, Budman SH, Fernandez KC, et al. Cross-validation of a screener to predict opioid misuse in chronic pain patients (SOAPP-R). J Addict Med 2009;3:66-73
52. Fishbain DA, Cole B, Lewis J, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors?. A structured evidence-based review. Pain Med 2008;9:444-459
53. Fleming MF, Davis J, Passik SD. Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med 2008;9:1098-1106
54. AVINZA® (morphine sulfate extended-release capsules) [package insert]. Bristol, TN: King Pharmaceuticals, Inc.; 2006
55. Caldwell JR, Rapoport RJ, Davis JC, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002;23:278-91
56. OPANA® ER (oxymorphone hydrochloride) extended-release tablets [package insert]. Chadds Ford, PA: Endo Pharmaceuticals Inc.; 2007
57. Matsumoto AK, Babul N, Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Med 2005;6:357-366
58. Kivitz A, Ma C, Ahdieh H, Galer BS. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006;28:352-364
59. Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain 2005;6:21-28
60. OXYCONTIN® (oxycodone HCl controlled-release) tablets [package insert]. Stamford, CT: Purdue Pharma L.P.; 2007
61. Markenson JA, Croft J, Zhang PG, Richards P. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005;21:524-535
62. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004;5:133-137
63. Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med 2000;160:853-860
64. Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999;26:862-869
65. ULTRAM® ER (tramadol HCl) Extended-Release Tablets [package insert]. Raritan, NJ: PriCara, a unit of Ortho-McNeil, Inc.; 2006
66. Babul N, Noveck R, Chipman H, et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004;28:59-71
67. Gana TJ, Pascual MLG, Fleming RRB, et al. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin 2006;22:1391-1401
68. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; CD006605
69. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No SMA 09-4434). Rockville, MD, USA. Available from: nsduhLatest.htm. [Last accessed 13 April 2010]
70. Substance Abuse and Mental Health Services Administration. Office of Applied Studies (5 February 2009). The NSDUH Report: trends in nonmedical use of prescription pain relievers: 2002 to 2007. Rockville, MD, USA. Available from: . gov/2k9/painRelievers/ nonmedicalTrends.cfm. [Last accessed 13 April 2010]
71. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999 - 2006. Available from: www.cdc.gov/nchs/data/databriefs/ db22.pdf. NCHS Data Brief 1-8 Sep 2009
72. Centers for Disease Control and Prevention. Overdose deaths involving prescription opioids among Medicaid enrollees - Washington, 2004 - 2007. MMWR Morb Mortal Wkly Rep 2009;58:1171-1175
73. Kuehn BM. FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen. JAMA 2009;302:369-371
74. Ballantyne JC. U.S. Opioid risk management initiatives. IASP Pain Clin Updat 2009;17:1-5